Anika Therapeutics buy Barrington Research
Start price
09.05.24
/
50%
€23.40
Target price
09.05.25
€34.32
Performance (%)
4.27%
Price
21.06.24
€24.40
Summary
This prediction is currently active. With a performance of 4.27%, the BUY prediction by Barrington_Research for Anika Therapeutics is trending in the right direction. This prediction currently runs until 09.05.25. The prediction end date can be changed by Barrington_Research at any time. Barrington_Research has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Anika Therapeutics | 0.826% | 0.826% |
iShares Core DAX® | 1.080% | -2.131% |
iShares Nasdaq 100 | 0.362% | 7.059% |
iShares Nikkei 225® | -1.155% | -0.483% |
iShares S&P 500 | 0.806% | 5.037% |
Comments by Barrington_Research for this prediction
In the thread Anika Therapeutics diskutieren
Anika Therapeutics, Inc. (NASDAQ: ANIK) had its "outperform" rating re-affirmed by analysts at Barrington Research. They now have a $37.00 price target on the stock.
Ratings data for ANIK provided by MarketBeat
Stopped prediction by Barrington_Research for Anika Therapeutics
Anika Therapeutics
Start price
Target price
Perf. (%)
€20.60
03.01.24
03.01.24
€26.58
03.01.25
03.01.25
17.48%
21.06.24
21.06.24
Anika Therapeutics
Start price
Target price
Perf. (%)
€19.70
03.11.23
03.11.23
€26.08
03.11.24
03.11.24
22.84%
21.06.24
21.06.24